Here's a fairy tale about a new hero in the fight against cancer... the PD-1 Checkpoint inhibitors. Currently, the PD-1 Inhibitors Nivolumab and Pembrolizumab have been approved for treating melanoma and non-small cell lung cancers and hopefully a lot more tumors in the future. This a very exciting development and will likely by tested! Check out Baronerocks.com for more fun ways to learn medicine!
26 авг 2024
